SUBSTITUTED N-BENZYL-LACTAM DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS

The present invention relates to novel substituted N-benzyl-lactam derivatives as melanocortin-4 receptor (MC-3R) agonists. The MC-4R agonists of the invention can be used for the treatment of disorders and diseases such as obesity, diabetes, and sexual dysfunction. All diseases and disorders where...

Full description

Saved in:
Bibliographic Details
Main Authors VON SPRECHER, ANDREAS, WEYERMANN, PHILIPP, SOEBERDT, MICHAEL
Format Patent
LanguageEnglish
French
Published 16.06.2005
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel substituted N-benzyl-lactam derivatives as melanocortin-4 receptor (MC-3R) agonists. The MC-4R agonists of the invention can be used for the treatment of disorders and diseases such as obesity, diabetes, and sexual dysfunction. All diseases and disorders where the activation of the MC-4R is involved can be treated with the compounds of the invention. L'invention concerne de nouveaux dérivés substitués utilisés en tant qu'agonistes du récepteur de la mélanocortine-4 (MC-3R). Les agonistes MC-4R selon l'invention peuvent être utilisés pour le traitement de troubles et de maladies telles que l'obésité, le diabète et la dysfonction sexuelle. Toutes les maladies et les troubles dans lesquels l'activation du MC-4R joue un rôle peuvent être traités à l'aide des composés selon l'invention.
Bibliography:Application Number: WO2004EP13862